Literature DB >> 9832942

Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats.

L Spina1, R Longoni, A Mulas, K J Chang, G Di Chiara.   

Abstract

The unconditioned behavioural effects of two non-peptide delta-opioid receptor agonists, BW 373U86 and SNC 80, were studied in the intact rat. BW 373U86 (0.1-2.5 mg/kg s.c.) and SNC 80 (2.5-10 mg/kg s.c.) dose-dependently elicited locomotion, rearing, stereotyped sniffing, licking and gnawing. These effects were abolished by pretreatment with the delta-opioid receptor antagonist naltrindole (5.0 mg/kg s.c.). In view of the phenomenological similarities between this syndrome and that elicited by dopamine-receptor agonists, the role played by dopamine receptors was investigated. The specific dopamine D1 receptor antagonist SCH 23390 and the specific dopamine D2/D3 receptor antagonist raclopride reduced or even abolished the behavioural stimulation induced by lower doses of BW 373U86 and SNC 80. When higher doses of BW 373U86 were used (2.5 mg/kg), however, raclopride, even at high cataleptic doses (6.0 mg/kg), only partly prevented the behavioural stimulation induced by the delta-opioid receptor agonist. The behavioural stimulation remaining after high doses of raclopride was abolished by the administration of SCH 23390. These results show that delta-opioid receptor stimulation elicits dopamine-dependent behavioural activation in the rat that depends on dopamine receptors, particularly of the D1 subtype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832942

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  15 in total

1.  Effects of delta opioid receptors activation on a response inhibition task in rats.

Authors:  Katia Befort; Megan K Mahoney; Carmen Chow; Scott J Hayton; Brigitte L Kieffer; Mary C Olmstead
Journal:  Psychopharmacology (Berl)       Date:  2010-12-23       Impact factor: 4.530

2.  Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats.

Authors:  Jay C Elliott; Mitchell J Picker; Andrew J Sparrow; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2006-01-06       Impact factor: 4.530

3.  Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.

Authors:  Emily M Jutkiewicz; Sarah T Kaminsky; Kenner C Rice; John R Traynor; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2005-07-13       Impact factor: 4.030

Review 4.  Delta Opioids: Neuroprotective Roles in Preclinical Studies.

Authors:  Shahid Husain
Journal:  J Ocul Pharmacol Ther       Date:  2018 Jan/Feb       Impact factor: 2.671

5.  In vivo mapping of a GPCR interactome using knockin mice.

Authors:  Jade Degrandmaison; Khaled Abdallah; Véronique Blais; Samuel Génier; Marie-Pier Lalumière; Francis Bergeron; Catherine M Cahill; Jim Boulter; Christine L Lavoie; Jean-Luc Parent; Louis Gendron
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-26       Impact factor: 11.205

6.  The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence.

Authors:  Glenn W Stevenson; Amy Luginbuhl; Catherine Dunbar; Justin LaVigne; Julio Dutra; Phillip Atherton; Brooke Bell; Katherine Cone; Denise Giuvelis; Robin Polt; John M Streicher; Edward J Bilsky
Journal:  Pharmacol Biochem Behav       Date:  2015-02-28       Impact factor: 3.533

7.  Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

Authors:  L Gendron; J E Pintar; C Chavkin
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

8.  Cocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment.

Authors:  Lisa M Ambrose-Lanci; R C Sterling; Elisabeth J Van Bockstaele
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

9.  The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.

Authors:  Gail Pereira Do Carmo; John E Folk; Kenner C Rice; Elena Chartoff; William A Carlezon; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2008-12-24       Impact factor: 4.432

10.  Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.

Authors:  H Beaudry; A Proteau-Gagné; Shuang Li; Y Dory; C Chavkin; L Gendron
Journal:  Neuroscience       Date:  2009-03-27       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.